Bonn et al. urge for a continuation of effective responses implemented during the pandemic, including emergency safe-supply prescribing and housing provision, and further efforts to address the harms of criminalisation and prohibition.
The Colombian Observatory of Organized Crime draws on lessons from the production of opium and cannabis for medical purposes to suggest pathways toward viable legal markets for coca products.
The Robert Carr Fund presents its 2019 annual report discussing the achievements in supporting the health, social inclusion and well-being of inadequately served populations.
Eggins et al. found that there is limited high-quality scientific evidence that can be used to examine the impact of the law-enforcement mechanisms of supplier arrest and seizure on a range of drug-related outcomes.
Using evidence from the HIV response, UNAIDS shines a light on forms of stigma encountered in six aspects of national; including education, the workplace, human rights, and emergency services.
The World Bank Group highlights the importance of scaling up treatment and prevention, including harm reduction methods and the benefits of sophisticated modelling.
The legalisation of the drug market as a way to undermine the power of organised crime groups and reducing the risk of vulnerable people by diminishing the opportunity and profit motive for human exploitation.
The Scottish Drug Forum presents a resource that allows people to understand contested terms and how language can result from and perpetuate stigma around people who use drugs.
The Global Initiative Against Transnational Organized Crime explores current debates on power, the use of force and inequality and concludes on the need to align responses to organised crime with a wider social justice agenda.
Colledge et al. found a high prevalence of injecting-related injuries and diseases, concluding on the need to expand health provision, particularly low-threshold services.
